Literature DB >> 17149879

Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide.

Gabriele Murineddu1, Paolo Lazzari, Stefania Ruiu, Angela Sanna, Giovanni Loriga, Ilaria Manca, Matteo Falzoi, Christian Dessì, Maria M Curzu, Giorgio Chelucci, Luca Pani, Gérard A Pinna.   

Abstract

New analogues (2a-p) of the previously reported CB(2) ligands 6-methyl- and 6-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexyilamine-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide (2a) was shown to have single digit nanomolar affinity for cannabinoid CB(2) receptors. Furthermore, compounds 2a and 2b, as well as lead structures 1a,b, were also shown to be agonist in an in vitro model based on human promyelocytic leukemia HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149879     DOI: 10.1021/jm060920d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

Review 1.  Gaq proteins: molecular pharmacology and therapeutic potential.

Authors:  Danielle Kamato; Partha Mitra; Felicity Davis; Narin Osman; Rebecca Chaplin; Peter J Cabot; Rizwana Afroz; Walter Thomas; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2016-11-04       Impact factor: 9.261

2.  Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS.

Authors:  Santhi Gorantla; Edward Makarov; Deepa Roy; Jennifer Finke-Dwyer; L Charles Murrin; Howard E Gendelman; Larisa Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-12       Impact factor: 4.147

3.  Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages.

Authors:  Jocelijn Meijerink; Mieke Poland; Michiel G J Balvers; Pierluigi Plastina; Carolien Lute; Jvalini Dwarkasing; Klaske van Norren; Renger F Witkamp
Journal:  Br J Pharmacol       Date:  2014-09-23       Impact factor: 8.739

Review 4.  Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Authors:  P Pacher; R Mechoulam
Journal:  Prog Lipid Res       Date:  2011-02-02       Impact factor: 16.195

Review 5.  Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking.

Authors:  J Hoggatt; L M Pelus
Journal:  Leukemia       Date:  2010-09-30       Impact factor: 11.528

6.  2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.

Authors:  Philippe Diaz; Sharangdhar S Phatak; Jijun Xu; Frank R Fronczek; Fanny Astruc-Diaz; Charles M Thompson; Claudio N Cavasotto; Mohamed Naguib
Journal:  ChemMedChem       Date:  2009-10       Impact factor: 3.466

7.  MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.

Authors:  M Naguib; P Diaz; J J Xu; F Astruc-Diaz; S Craig; P Vivas-Mejia; D L Brown
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

8.  Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.

Authors:  Servio H Ramirez; Nancy L Reichenbach; Shongshan Fan; Slava Rom; Steven F Merkel; Xu Wang; Wen-Zhe Ho; Yuri Persidsky
Journal:  J Leukoc Biol       Date:  2013-03-05       Impact factor: 4.962

9.  Activation of cannabinoid receptor 2 inhibits experimental cystitis.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-20       Impact factor: 3.619

10.  Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  J Psychopharmacol       Date:  2012-07-11       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.